Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07449858
Eligibility Criteria:
Inclusion Criteria:
* Age \>= 18 years.
* Underwent standard whole-body 18F-FDG PET/CT scan within 30 days before surgery.
* Histopathologically confirmed Non-Small Cell Lung Cancer (NSCLC) with clear histological subtyping and complete postoperative TNM staging.
* Primary tumor SUVmax \> 2.5 and maximum diameter \> 1.0 cm on CT.
* Complete clinical, pathological, and imaging data available.
* (For Gene Sub-study) Known EGFR gene mutation status.
* (For Prognosis Sub-study) Complete follow-up data available (minimum 12 months or until endpoint event).
Exclusion Criteria:
* History of other malignancies.
* Received any anti-tumor treatment (chemotherapy, radiotherapy, targeted therapy, immunotherapy) prior to PET/CT.
* Severe image artifacts or indistinct tumor boundaries affecting ROI delineation.
* Missing key clinical or pathological data.
* Baseline PET/CT evaluated recurrent or metastatic tumors instead of primary NSCLC.
* Extremely short life expectancy due to severe comorbidities.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07449858
Study Brief:
Protocol Section:
NCT07449858